Brian J. Barnes

628 total citations
30 papers, 354 citations indexed

About

Brian J. Barnes is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Brian J. Barnes has authored 30 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Geriatrics and Gerontology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brian J. Barnes's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Poisoning and overdose treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brian J. Barnes is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Poisoning and overdose treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brian J. Barnes collaborates with scholars based in United States, Bangladesh and United Kingdom. Brian J. Barnes's co-authors include Patricia Howard, James M. Hollands, Michael E. Mullins, Jennifer R. Smith, Andrea R. Terrell, Dennis Grauer, Antonia Zapantis, Rebecca T. Horvat, Melinda K. Lacy and James L. Vacek and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and Critical Care Medicine.

In The Last Decade

Brian J. Barnes

26 papers receiving 335 citations

Peers

Brian J. Barnes
Vijay Krishnamoorthy United States
Aida Kulo Bosnia and Herzegovina
Matthew Sigakis United States
Deepali Dixit United States
Leslie A. Hamilton United States
Vijay Krishnamoorthy United States
Brian J. Barnes
Citations per year, relative to Brian J. Barnes Brian J. Barnes (= 1×) peers Vijay Krishnamoorthy

Countries citing papers authored by Brian J. Barnes

Since Specialization
Citations

This map shows the geographic impact of Brian J. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Barnes more than expected).

Fields of papers citing papers by Brian J. Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Barnes. The network helps show where Brian J. Barnes may publish in the future.

Co-authorship network of co-authors of Brian J. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Barnes. A scholar is included among the top collaborators of Brian J. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Barnes. Brian J. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bleyer, Archie, et al.. (2024). United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic. Journal of Opioid Management. 20(2). 119–132. 1 indexed citations
2.
Barnes, Brian J., et al.. (2023). Risk-Based Monitoring in Clinical Trials: 2021 Update. Therapeutic Innovation & Regulatory Science. 57(3). 529–537. 10 indexed citations
3.
Barnes, Brian J., et al.. (2022). Risk-Based Monitoring in Clinical Trials: Increased Adoption Throughout 2020. Therapeutic Innovation & Regulatory Science. 56(3). 415–422. 11 indexed citations
4.
Barnes, Brian J., et al.. (2022). 508 Comparing effectiveness and safety of levetiracetam loading doses among patients with status epilepticus.. Journal of Clinical and Translational Science. 6(s1). 103–103.
5.
Bleyer, Archie, et al.. (2022). United States marijuana legalization and opioid mortality epidemic during 2010–2020 and pandemic implications. Journal of the National Medical Association. 114(4). 412–425. 5 indexed citations
6.
Barnes, Brian J., et al.. (2021). Risk-Based Monitoring in Clinical Trials: Past, Present, and Future. Therapeutic Innovation & Regulatory Science. 55(4). 899–906. 19 indexed citations
7.
Barnes, Brian J., et al.. (2021). Bulbar urethrocavernous fistula in setting of inflatable penile prosthesis: a case report. BMC Urology. 21(1). 25–25. 1 indexed citations
8.
Pandian, Vinciya, Brian J. Barnes, Elizabeth King, et al.. (2020). The Trach Trail: A Systems‐Based Pathway to Improve Quality of Tracheostomy Care and Interdisciplinary Collaboration. Otolaryngology. 163(2). 232–243. 26 indexed citations
9.
Johnson, Courtney, et al.. (2014). Impact of a community-based diabetes self-management program on key metabolic parameters. Pharmacy Practice. 12(4). 0–0. 6 indexed citations
10.
Nennecke, Alice, Brian J. Barnes, Hermann Brenner, et al.. (2013). [Data quality or differences in oncological care? - standards of reporting for cancer survival analyses based on registry data].. Das Gesundheitswesen. 75(2). 94–8. 2 indexed citations
11.
Kramer, Jeffrey B., Patricia Howard, Brian J. Barnes, et al.. (2012). Secondary Prevention Following Coronary Artery Bypass Surgery: A Pilot Study for Improved Patient Education. International Journal of Clinical Medicine. 3(4). 286–294. 1 indexed citations
12.
Ruisinger, Janelle F., et al.. (2012). Community pharmacy-based medication therapy management services: financial impact for patients. Pharmacy Practice. 10(3). 119–124. 13 indexed citations
13.
Ruisinger, Janelle F., et al.. (2012). Study of nonparticipation in an employee diabetes program. Journal of the American Pharmacists Association. 52(5). e105–e108. 1 indexed citations
14.
Howard, Patricia, et al.. (2010). Impact of Bisphosphonates on the Risk of Atrial Fibrillation. American Journal of Cardiovascular Drugs. 10(6). 359–367. 19 indexed citations
15.
Barnes, Brian J. & James M. Hollands. (2010). Drug-induced arrhythmias. Critical Care Medicine. 38(6 Suppl). S188–S197. 45 indexed citations
16.
Barnes, Brian J., Patricia Howard, Dennis Grauer, et al.. (2006). Risk-Stratified Evaluation of Amiodarone to Prevent Atrial Fibrillation After Cardiac Surgery. The Annals of Thoracic Surgery. 82(4). 1332–1337. 10 indexed citations
17.
Barnes, Brian J., et al.. (2006). Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(1). 23–33. 54 indexed citations
18.
Micek, Scott T., Brian J. Barnes, Dennis Grauer, & Daniel Johnson. (2004). LONG-TERM SEDATION WITH PROTOCOL-DIRECTED MIDAZOLAM AND LORAZEPAM: A COST-EFFECTIVENESS ANALYSIS. Critical Care Medicine. 32(Supplement). A174–A174. 3 indexed citations
19.
Barnes, Brian J., Nathan P. Wiederhold, Scott T. Micek, Louis B. Polish, & David J. Ritchie. (2003). Enterobacter cloacae Ventriculitis Successfully Treated with Cefepime and Gentamicin: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(4). 537–542. 14 indexed citations
20.
Barnes, Brian J.. (2002). UTILITY OF OSMOLAR GAP AS A SURROGATE MARKER FOR PROPYLENE GLYCOL SERUM CONCENTRATION IN CRITICALLY ILL PATIENTS RECEIVING LORAZEPAM FOR SEDATION. Critical Care Medicine. 30(Supplement). A157–A157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026